Biliary proteins and their redox status changes in gallstone patients (original) (raw)

Abstract

Background Proteins might act as pronucleating agents of cholesterol crystallization in bile. However, little is known about the redox status of biliary proteins in humans and their interaction with crystallization of biliary cholesterol.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (50)

  1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone dis- ease. Lancet 2006;368:230-9.
  2. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002;35:1507-12.
  3. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Good- man C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-11.
  4. Wang DQH, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 2004;6:140-50.
  5. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991;20:1-19.
  6. Portincasa P, Di Ciaula A., Wang HH, Palasciano G, van Erpecum KJ, Moschetta A, et al. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 2008;47:2112-26.
  7. Wang HH, Portincasa P, Wang DQ. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci 2008;13:401-23.
  8. Jungst C, Sreejayan N, Eder MI, von SN, Zundt B, Spelsberg FW, et al. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients. Eur J Clin Invest 2007;37:731-6.
  9. 9 Sheen PC, Lee KT, Liu YE. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periph- ery. Digestion 1998;59:660-4.
  10. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gall- stone disease. Gastroenterology 1979;77:611-17.
  11. van Erpecum KJ, van Berge-Henegouwen GP, Stoelwinder B, Stolk MF, Eggink WF, Govaert WH. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differen- tiation between the two stone types. Scand J Gastroenterol 1988;23:948-54.
  12. van Erpecum KJ, van Berge-Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990;11: 1-6.
  13. Portincasa P, van Erpecum KJ, Jansen A, Renooij W, Gadellaa M, van Berge-Henegouwen GP. Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology 1996;23:738-48.
  14. van Erpecum KJ, Portincasa P, Eckhardt E, Go PMNYH, van Berge- Henegouwen GP, Groen AK. Ursodeoxycholic acid reduces protein levels and their nucleation-promoting activity in gallbladder bile. Gastroenterology 1996;110:1225-37.
  15. Wilhelmi M, Jungst C, Mock M, Meyer G, Zundt B, Del PR, et al. Effect of gallbladder mucin on the crystallization of cholesterol in bile. Eur J Gastroenterol Hepatol 2004;16:1301-7.
  16. Geetha A. Evidence for oxidative stress in the gall bladder mucosa of gall stone patients. J Biochem Mol Biol Biophys 2002;6:427-32.
  17. Soloway RD, Weinman SA. Oxidative stress as a cause of biliary lithiasis: new possibilities for medical therapy of stones or a false alarm? Hepatology 2000;32:670-1.
  18. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutri- tion Examination Survey (NHANES III). Arch Intern Med 2000;160:931-6.
  19. Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: Prolongation of the nucleation time. Eur J Clin Invest 1997;27:387-91.
  20. Elek G, Rockenbauer A. The free radical signal of pigment gall- stones. Klin Wochenschr 1982;60:33-5.
  21. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000;899:191-208.
  22. Grattagliano I, Russmann S, Palmieri VO, Juni P, Bihl F, Portincasa P, et al. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. Hepatology 2004;39:1248-55.
  23. Jirsa M, Groen AK. Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallisation and gallstone growth. Front Biosci 2001;6:E154-E167.
  24. Gallinger S, Harvey PRC, Petrunka CN, Ilson RG, Strasberg SM. Bili- ary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology 1987;92:867-75.
  25. Tudyka J, Kratzer W, Kuhn K, Mason R, Wechsler JG, Adler G. Soli- tary versus multiple gallstones: the importance of total biliary pro- tein concentration and other factors. Hepatogastroenterology 1995;42:638-44.
  26. van Erpecum KJ, Portincasa P, Dohlu MH, van Berge-Henegouwen GP, Jungst D. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. J Hepatol 2003;39:7-11.
  27. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri VO, Moschetta A, van Berge-Henegouwen GP, et al. Gallbladder motility and cho- lesterol crystallization in bile from patients with pigment and cho- lesterol gallstones. Eur J Clin Invest 2000;30:317-24.
  28. Trotman BW, Ostrow JD, Soloway RD. Pigment vs cholesterol chole- lithiasis: comparison of stone type and bile composition. Am J Dig Dis 1974;19:585-90.
  29. Tera H Stratification of human gallbladder in vivo. Acta Chir Scand 1960;suppl 256: 4-85.
  30. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and pur- ification. Can J Biochem Physiol 1959;37:911-17.
  31. Wang DQH, Carey MC. Complete mapping of crystallization path- ways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and iden- tification of a stable liquid crystalline state in cold, dilute and hydro- philic bile salt-containing system. J Lipid Res 1996;37:606-30.
  32. Fromm H, Hamin P, Klein H, Kupke I. Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res 1980;21:259- 61.
  33. Turley SD, Dietschy JM. Reevaluation of the 3a-hydroxy-steroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978;19:924-8.
  34. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
  35. Grattagliano I, Vendemiale G, Sabba C, Buonamico P, Altomare E. Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xanthine oxidase. J Hepatol 1996;25:28-36.
  36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified pro- teins. Methods Enzymol 1990;186:464-78.
  37. Armitage P, Berry G Statistical methods in medical research, Oxford: Blackwell Science Ltd, 1994.
  38. Dawson B, Trapp RG Basic & Clinical Biostatistics, New York: McGraw-Hill, 2001.
  39. Groen AK, Stout JPJ, Drapers JAG, Hoek FJ, Grijm R, Tytgat GNJ. Cholesterol nucleation influencing activity in T-tube bile. Hepatology 1988;8:347-52.
  40. Boisier X, Schon M, Sepulveda A, Basualdo A, Cornejo P, Bosco C, et al. Derangement of Kupffer cell functioning and hepatotoxicity in hyperthyroid rats subjected to acute iron overload. Redox Rep 1999;4:243-50.
  41. Shiesh SC, Chen CY, Lin XZ, Liu ZA, Tsao HC. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 2000;32:455-60.
  42. Swartz-Basile DA, Goldblatt MI, Blaser C, Decker PA, Ahrendt SA, Sarna SK, et al. Iron deficiency diminishes gallbladder neuronal nitric oxide synthase. J Surg Res 2000;90:26-31.
  43. Johnston SM, Murray KP, Martin SA, Fox-Talbot K, Lipsett PA, Lillemoe KD, et al. Iron deficiency enhances cholesterol gallstone formation. Surgery 1997;122:354-61.
  44. Lin C, Shen T, Fu X, Zhou X. The ability of bile to scavenge superox- ide radicals and pigment gallstone formation in guinea pigs. HPB Surg 1996;10:73-6.
  45. Carey MC. Pathogenesis of gallstones. Am J Surg 1993;165:410-9.
  46. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenter- ology 1999;116:1420-7.
  47. Sandstad O, Osnes T, Urdal P, Skar V, Osnes M. Brown pigment stones in the common bile duct: reduced bilirubinate diconjugate in bile. Scand J Gastroenterol 2000;35:198-203.
  48. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 2009;106:5171-6.
  49. Holloway DE, Rivers JM. Influence of chronic ascorbic acid defi- ciency and excessive ascorbic acid intake on bile acid metabolism and bile composition in the guinea pig. J Nutr 1981;111:412-24.
  50. Peters WH, van SA, Peters JH, van GH. Oxidised-and total non-pro- tein bound glutathione and related thiols in gallbladder bile of patients with various gastrointestinal disorders. BMC Gastroenterol 2007;7:7.